APAndrey Gennadievich Popandopulo

Andrey Gennadievich Popandopulo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrey Gennadievich Popandopulo has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Probiotics in the Treatment of Infected Wounds: Current State and Delivery Technologies

    by Margarita A. Belotserkovskaya, Olga E. Voronko, Margarita P. Markina, Vagif A. Gasanov, Viktor V. Turchyn, Maksim V. Solopov, Kirill O. Golubitskiy, Roman V. Ischenko, Dmitry A. Filimonov, Andrey G. Popandopulo

    Wound infections remain a challenging problem in modern medicine amid the growing antimicrobial resistance of pathogens. Topical probiotics, primarily representatives of the genera Lactobacillus and Bifidobacterium, are considered as a promising alternative to traditional antibiotics due to their ability to suppress pathogen growth, disrupt biofilms, modulate immune response, stimulate tissue regeneration, and restore the wound microbiome. Despite encouraging preclinical data, the clinical application of live probiotics is constrained by technological barriers related to bacterial instability, the need to maintain their viability, and the risk of systemic dissemination. This review systematizes the current understanding of the mechanisms of action of probiotics in wound infection, particularly for topical application, and analyzes their delivery technologies, including hydrogels, microparticles, nanofibers, and hybrid systems. Preclinical and clinical studies, challenges in clinical translation, and promising directions for future research are also discussed. In conclusion, the combination of topical live probiotics with hybrid delivery systems has demonstrated encouraging efficacy in preclinical settings; however, its translation into clinical trials will require standardization of dosages and delivery protocols, as well as further improvement of safety profiles.

  • Open Access

    Bio-Based Hemostatic Adhesives, Sealants, and Local Hemostatic Agents for Liver Tissue: A Systematic Review with Meta-Analysis of Preclinical Data

    by Roman Ishchenko, Maksim Solopov, Matvey Ilyashenko, Viktor Turchin, Dmitry Filimonov, Tatiana Kryuk, Anna Kavelina, Gulnara Akopian, Viktoria Bushe, Elizaveta Lebed, et al.

    Background: Liver surgery carries a high risk of hemorrhage; bio-based adhesives and sealants are promising adjuncts, but hepatic evidence remains fragmented. Methods: Following PRISMA 2020, we searched PubMed, Dimensions, Consensus, and SciSpace through February 2026. Forty-two studies were included (38 preclinical animal, 3 human clinical, and 1 veterinary RCT); 25 preclinical studies (67 pairwise comparisons) underwent random-effects meta-analysis using REML with HKSJ adjustment. Risk of bias was assessed with SYRCLE, RoB 2, and ROBINS-I; certainty of evidence was rated with an adapted GRADE framework. Results: Versus standard hemostats, bioadhesives shortened time to hemostasis (MD = +56.05 s, 95% CI: 20.14 to 91.96; p = 0.0044) and reduced blood loss (RoM = 2.05, 95% CI: 1.48 to 2.86; p = 0.0002); versus untreated negative controls, effects were larger (MD = +419.53 s; RoM = 5.68). Heterogeneity was extreme (I2 = 96–99%), 95% prediction intervals included the null, and available clinical effect sizes were small and non-significant. Certainty of evidence was low to very low. Conclusions: Bio-based adhesives show substantial preclinical hemostatic effects in liver models, but these findings should not be interpreted as established clinical benefit. Adequately powered multicenter RCTs with standardized outcome assessment are required.

  • Open Access

    Effect of Combined Iron Oxide Magnetic Nanoparticles and Magnetic Field Exposure on Osteogenic Differentiation of Mesenchymal Stem Cells: A Systematic Review and Meta-Analysis

    by Maksim Solopov, Roman Ishchenko, Viktor Turchin, Viktoria Bushe, Anna Kavelina, Gulnara Akopian, Elizaveta Lebed, Andrey Popandopulo

    Combined iron oxide magnetic nanoparticles (MNPs) and external magnetic fields (MFs) are explored to direct osteogenic differentiation of mesenchymal stem cells (MSCs) in bone tissue engineering, yet exposure parameters vary widely. This systematic review and meta-analysis searched PubMed and Dimensions, with Consensus and SciSpace as exploratory scoping aids (final search 22 November 2025). Twenty-five studies entered qualitative synthesis and twenty-two quantitative synthesis (‘MNP + MF’ vs. ‘MNP without MF’; standardized mean difference [SMD] as Hedges’ g; restricted maximum likelihood random-effects model with Hartung–Knapp–Sidik–Jonkman confidence intervals [CIs]). Across nine outcomes, effect directions were predominantly positive; uncorrected significance held only for alkaline phosphatase (ALP) activity (SMD = +4.42; 95% CI 0.97–7.86; k = 14) and mineralization (SMD = +2.41; 0.03–4.80; k = 7). After Holm correction, no outcome remained significant. Heterogeneity was critical (I2 > 75% for five outcomes). Funnel–plot asymmetry for ALP suggested possible small-study effects; trim-and-fill reduced the pooled SMD to +1.34 (−1.60–4.27). Findings constitute a low-certainty, hypothesis-generating signal rather than confirmed efficacy; standardized protocols and blinded designs are needed before translational claims.

  • Open Access

    Robotic XY-scanning platform for three-dimensional analysis of ex vivo models of superficial wounds

    by M. V. Solopov, A. G. Popandopulo, V. V. Turchin, A. A. Ermak, S. A. Rudskoy, R. V. Ishchenko, М. В. Солопов, А. Г. Попандопуло, В. В. Турчин, А. А. Ермак, et al.

    Accurate measurement of wound geometric parameters is essential for assessing injury severity and monitoring healing progress. Traditional manual methods have significant limitations: high error rates, subjectivity, and risk of infection. Modern digital techniques lack these drawbacks but are often expensive and complex. This study presents an alternative solution: an automated scanning platform assembled from affordable components.    Aim of the study  was to develop and validate a robotic XY-scanning platform for automated 3D analysis of ex vivo models of superficial skin wounds and to evaluate its accuracy compared to standard manual measurement methods.    Material and methods.  The hardware of the platform was developed using an Arduino Uno microcontroller, 28BYJ-48 stepper motors, and a Sharp 2Y0A21 infrared distance sensor. The software controls the scanning process and calculates wound parameters: volume (using Simpson’s method), area (using the Gaussian formula), and maximum depth. For validation, six model wounds with varying geometries were created on porcine skin samples. Their parameters were independently measured by the automated system and manual methods: volume by filling with saline solution, depth with a caliper, and area by planimetry in ImageJ software.    Results.  Statistical analysis demonstrated high agreement between automated and manual measurements. The highest accuracy was achieved in volume assessment: the mean difference between methods (0.37 cm 3 , p = 0.156), Spearman’s (ρ = 1.00) and Lin’s concordance correlation coefficient (> 0.98) indicated nearly perfect concordance. Depth measurements also showed high reliability, despite a minor systematic underestimation by the automated system averaging 0.99 mm (p = 0.094). A strong monotonic relationship was confirmed (ρ = 0.94). For wound area, a statistically significant systematic bias was identified: the platform consistently overestimated values by an average of 1.98 cm 2 (p = 0.031), likely due to hardware limitations and insufficient system resolution.    Conclusions.  The developed platform proved effective for automated, non-contact measurement of wound volume and depth, combining component affordability and automation. The main limitation is a systematic error in area measurement. Future work involves hardware modernization (installing a high-precision laser sensor) and further validation on an expanded sample of various wound types for implementation in clinical and research practice.

  • Open Access

    Efficacy of the stromal vascular fraction in experimental models of bone regeneration: a systematic review

    by Anna S. Kavelina, Gulnara V. Akopyan, Maksim V. Solopov, Viktor V. Turchin, Victoria V. Bushe, Elizaveta D. Lebed, Andrey G. Popandopulo

    Significant heterogeneity in stromal vascular fraction (SVF) isolation protocols and interspecies differences limit the standardization of cell therapy for bone defects. The aim of the study: To systematize data from experimental in vivo studies by evaluating the influence of adipose tissue sources, isolation methods, and dosing on regeneration efficacy. Research methodology: Following PRISMA 2020 guidelines, a PubMed search was conducted (2014–2024). Original studies containing quantitative SVF composition parameters and verified osteogenesis outcomes were analyzed. The results of the research: Thirty-eight studies were included in the review. Native SVF demonstrates a favorable safety profile, stimulating reparative osteogenesis and neoangiogenesis following both local and systemic administration. The "point-of-care" approach minimizes regulatory barriers. Adipose tissue harvest volume was found to be species-specific: 4–5 g (rats), 2–6 g (rabbits), 5–50 g (dogs), ~15 g (sheeps), ~100 g (goats), and 20 g (horses) with a mean cell yield of 0.5–3.15 × 106 cells/g of tissue. Reference single dose per defect were established: 1.5–12 × 106 cells/mL (rodents), 6–16 × 106 cells/mL (rabbits) and 5–60×106 cells/mL (large animals). Optimal seeding density on scaffolds was 18–40 × 106 cells/cm³. Combining SVF with blood-derived products (PRP, tPRP, WP) accelerated osteogenesis 3.7-fold and increased M2 macrophage density 6.9-fold, enabling a xenogeneic-free strategy. For critical-sized defects, monotherapy was inferior to combinatorial approaches: integration of SVF with bioceramics and polymeric matrices (β-TCP, BCP, chitosan, 3D-printed constructs) enhanced mechanical integration by 150 % and accelerated mineralization up to 8-fold. Conclusion: SVF is an effective tool for bone repair when cell loading is adjusted for species-specific requirements. Interspecies variability necessitates the development of differentiated dosing protocols to support successful clinical translation.

  • Cell-specific expression of trace amine receptor 1 (TAAR1) in neurons across brain regions: transcriptome analysis using publicly available databases

    by D. A. Filimonov, M. Yu. Kotlovskiy, M. P. Potapov, M. A. Belotserkovskaya, A. G. Popandopulo, N. N. Trubnikova, I. A. Kisilenko, M. V. Solopov, V. V. Turchin

    Relevance. Trace amine-associated receptor-1 (TAAR1) mediates signaling through a broad spectrum of agonists that function as neuromodulators in classical neurotransmitter systems and may also potentially exert a neuroprotective effect. Objective. The aim of this study was to determine the expression pattern of TAAR1 in brain cells and tissues by analyzing publicly available gene expression databases. Materials and methods. TAAR1 gene expression was analyzed using datasets from the Allen Institute for Brain Science (Human Brain Atlas Microarray, Allen Brain Cell Atlas, Brain Allen Developing Human Brain Atlas, and Whole Mouse Brain Transcriptomic Cell Type Atlas). Results. Analysis of public transcriptomic databases revealed TAAR1 expression in the human cerebral cortex, amygdala, basal ganglia, hippocampus, and thalamus. Marked differences between human and mouse data indicate probable interspecies differences in TAAR1 expression. Conclusion. TAAR1 exhibits a heterogeneous and predominantly low-grade distribution within the central nervous system, highlighting the need for modern single-nucleus/single-cell sequencing methods and the development of in vivo approaches to receptor imaging.

  • Open Access

    Therapeutic effects of probiotics in topical treatment of infected wounds

    by Roman V. Ishchenko, Kirill O. Golubitskiy, Maksim Vital'Evich Solopov, Irina Alexandrovna Kisilenko, Margarita Andreevna Belotserkovskaya, Viktor V. Turchyn, Dmitry Alekseevich Filimonov, Andrey Gennadievich Popandopulo, Vagif Ali Ogly Gasanov

    Wound infections, exacerbated by antibiotic resistance and biofilm formation, necessitate alternative therapeutic options. One promising approach is topical bacteriotherapy with live probiotics. The work aimed to summarize existing research on the multifaceted effects of live probiotics in infected wound healing. The review examines how probiotics directly influence pathogenic wound microflora by competing for adhesion sites and nutrients, secreting antagonistic compounds, altering the wound environment, and promoting co-aggregation. Probiotics’ antibiofilm activity is highlighted, including inhibition of quorum sensing systems and disruption of the extracellular biofilm matrix. Moreover, the review discusses the findings of in vitro and in vivo studies on the effects of live probiotics on macroorganisms. Probiotics have been shown to activate signaling pathways that regulate macrophage shift from a pro-inflammatory (M1) phenotype to a pro-repair (M2) phenotype, cytokine synthesis, keratinocyte and fibroblast migration and proliferation, angiogenesis, and collagen matrix formation. Thus, the multifaceted effects of probiotics cannot be replicated by metabolites or inactivated cells alone, highlighting the need for effective delivery systems for live probiotic cultures in infected wound management.

  • Open Access

    Magnetic particles and targeting systems for magnetic cell delivery

    by Viktor V. Turchyn, Roman V. Ishchenko, Svetlana Vladimirovna Bespalova, Maxim Vital'Evich Solopov, Yuri Anatolyevich Legenkiy, Dmitry Alexeevich Filimonov, Andrey Gennadievich Popandopulo

    BACKGROUND: The number of studies investigating physical methods of cell targeting is steadily growing. Within the field of magnetic cell targeting, two main approaches have recently emerged: the use of microscale structures as magnetic carriers, e.g, porous spheroids, helices, and microrobots, that transport cells, and the use of nano- or microscale magnetic particles that directly label cells. AIM: The study aimed to review experimental studies on the use of magnetic particles for targeted delivery of mammalian cells in order to identify the main parameters of magnetic labeling and targeting systems. METHODS: Scientific data was searched in the PubMed, Cochrane Library, and eLIBRARY.RU databases for the period from January 2019 to September 2024 using the keywords magnetic cell targeting, magnetic cell delivery, magnetic cell localization, and magnetic cell guidance. Original experimental in vitro and in vivo studies were included if they involved labeling mammalian or human cells with magnetic nano- or microparticles for targeted delivery using magnetic fields. Data on study design, cell lines used, characteristics of magnetic particles, magnetic labeling conditions and efficiency, characteristics of magnetic trapping systems, efficiency of magnetic delivery, and clinical effects in in vivo disease models were extracted from the selected articles. RESULTS: A total of 62 articles were included in the analysis, of which 63% (39 studies) involved animal disease models, mainly affecting the nervous system, heart, eyes, urinary system, musculoskeletal system, and cancer. The most common labeled cells were multipotent mesenchymal stromal cells (27 studies), immune system cells (16 studies), and endothelial cells and their progenitors (7 studies). In most studies, superparamagnetic iron oxide nanoparticles were used for cell labeling (82% of studies) with more than 30 types of coatings, whereas neodymium magnets of various configurations at 0.005–1.450 T magnetic induction served as targeting systems. In 84% of studies, the optimal labeling concentration of magnetic particles ranged from 10–100 µg Fe/mL, with a labeling time of 4–24 h. A high degree of labeled cell magnetic controllability was demonstrated in vitro. In 19 animal studies, magnetic targeting resulted in a 1.16- to 20-fold increase in local cell concentration within the target area. In 85% of in vivo studies, magnetic targeting produced a more pronounced therapeutic effect compared with controls without targeting systems. Overall, the analysis confirms the high clinical potential of magnetic targeting in cell therapy. CONCLUSION: Magnetic targeting of cells using magnetic particles is a rapidly developing and promising technology in the field of regenerative medicine and cell therapy.

  • Open Access

    Comparative analysis of machine learning models for predicting anthracycline-induced cardiotoxicity in patients with hematologic malignancies

    by M. A. El-Khatib, M. V. Solopov, E. V. Sklyannaya, A. G. Popandopulo

    Objective: a comparative study of various machine learning algorithms (AdaBoost, k-nearest neighbors, linear discriminant analysis, logistic regression, neural networks, random forest, stochastic gradient descent, support vector machines, XGBoost) for predicting anthracycline-induced cardiotoxicity (AIC) in patients with haematological cancer using clinical and instrumental predictors. Material and Methods . A prospective study included 155 haematological cancer patients receiving anthracycline-containing therapy. The age of the patients ranged from 18 to 74 years. Clinical data, biomarker levels (NT-proBNP, troponin I), and echocardiographic parameters of diastolic function (E’, E/E’, LAVI) were analyzed. Data underwent preprocessing (standardization, one-hot encoding), and class imbalance was addressed using SMOTETomek. Models were trained and evaluated via 5-fold stratified cross-validation using F1-score, AUC-ROC, precision, and recall metrics. Results. Statistically significant predictors of AIC included NT-proBNP (pConclusion. Linear models, particularly logistic regression, exhibit high accuracy and reliability in predicting AIC using combined biomarkers and echocardiographic diastolic function parameters. These models show potential for clinical implementation in risk stratification and timely initiation of cardioprotective therapy. Further validation across multi-center patient cohorts is warranted.

  • Open Access

    Current Trends and Future Opportunities of AI-Based Analysis in Mesenchymal Stem Cell Imaging: A Scoping Review

    by Maksim Solopov, Elizaveta Chechekhina, Viktor Turchin, Andrey Popandopulo, Dmitry Filimonov, Anzhelika Burtseva, Roman Ishchenko

    This scoping review explores the application of artificial intelligence (AI) methods for analyzing mesenchymal stem cells (MSCs) images. The aim of this study was to identify key areas where AI-based image processing techniques are utilized for MSCs analysis, assess their effectiveness, and highlight existing challenges. A total of 25 studies published between 2014 and 2024 were selected from six databases (PubMed, Dimensions, Scopus, Google Scholar, eLibrary, and Cochrane) for this review. The findings demonstrate that machine learning algorithms outperform traditional methods in terms of accuracy (up to 97.5%), processing speed and noninvasive capabilities. Among AI methods, convolutional neural networks (CNNs) are the most widely employed, accounting for 64% of the studies reviewed. The primary applications of AI in MSCs image analysis include cell classification (20%), segmentation and counting (20%), differentiation assessment (32%), senescence analysis (12%), and other tasks (16%). The advantages of AI methods include automation of image analysis, elimination of subjective biases, and dynamic monitoring of live cells without the need for fixation and staining. However, significant challenges persist, such as the high heterogeneity of the MSCs population, the absence of standardized protocols for AI implementation, and limited availability of annotated datasets. To advance this field, future efforts should focus on developing interpretable and multimodal AI models, creating standardized validation frameworks and open-access datasets, and establishing clear regulatory pathways for clinical translation. Addressing these challenges is crucial for accelerating the adoption of AI in MSCs biomanufacturing and enhancing the efficacy of cell therapies.